ACHIEVE LIFE SCIENCES INC (ACHV) Stock Fundamental Analysis

NASDAQ:ACHV • US0044685008

4.27 USD
-0.1 (-2.29%)
At close: Feb 20, 2026
4.15 USD
-0.12 (-2.81%)
After Hours: 2/20/2026, 8:15:46 PM
Fundamental Rating

1

Taking everything into account, ACHV scores 1 out of 10 in our fundamental rating. ACHV was compared to 521 industry peers in the Biotechnology industry. ACHV has a bad profitability rating. Also its financial health evaluation is rather negative. ACHV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year ACHV has reported negative net income.
  • ACHV had a negative operating cash flow in the past year.
  • ACHV had negative earnings in each of the past 5 years.
  • ACHV had a negative operating cash flow in each of the past 5 years.
ACHV Yearly Net Income VS EBIT VS OCF VS FCFACHV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • The Return On Assets of ACHV (-100.59%) is worse than 75.05% of its industry peers.
  • ACHV has a Return On Equity of -155.72%. This is in the lower half of the industry: ACHV underperforms 64.49% of its industry peers.
Industry RankSector Rank
ROA -100.59%
ROE -155.72%
ROIC N/A
ROA(3y)-132.77%
ROA(5y)-100.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACHV Yearly ROA, ROE, ROICACHV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K 2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ACHV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACHV Yearly Profit, Operating, Gross MarginsACHV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

3

2. Health

2.1 Basic Checks

  • The number of shares outstanding for ACHV has been increased compared to 1 year ago.
  • The number of shares outstanding for ACHV has been increased compared to 5 years ago.
  • The debt/assets ratio for ACHV has been reduced compared to a year ago.
ACHV Yearly Shares OutstandingACHV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACHV Yearly Total Debt VS Total AssetsACHV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of -1.42, we must say that ACHV is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -1.42, ACHV perfoms like the industry average, outperforming 53.93% of the companies in the same industry.
  • A Debt/Equity ratio of 0.26 indicates that ACHV is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.26, ACHV is doing worse than 66.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -1.42
ROIC/WACCN/A
WACCN/A
ACHV Yearly LT Debt VS Equity VS FCFACHV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • ACHV has a Current Ratio of 5.14. This indicates that ACHV is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ACHV (5.14) is comparable to the rest of the industry.
  • A Quick Ratio of 5.14 indicates that ACHV has no problem at all paying its short term obligations.
  • ACHV has a Quick ratio of 5.14. This is comparable to the rest of the industry: ACHV outperforms 58.54% of its industry peers.
Industry RankSector Rank
Current Ratio 5.14
Quick Ratio 5.14
ACHV Yearly Current Assets VS Current LiabilitesACHV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

1

3. Growth

3.1 Past

  • ACHV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.12%.
EPS 1Y (TTM)-22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ACHV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.52% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-3.94%
EPS Next 2Y3.32%
EPS Next 3Y23.61%
EPS Next 5Y28.52%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACHV Yearly Revenue VS EstimatesACHV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2021 2022 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
ACHV Yearly EPS VS EstimatesACHV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -500 -1K -1.5K -2K

1

4. Valuation

4.1 Price/Earnings Ratio

  • ACHV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ACHV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACHV Price Earnings VS Forward Price EarningsACHV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACHV Per share dataACHV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ACHV's earnings are expected to grow with 23.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.32%
EPS Next 3Y23.61%

0

5. Dividend

5.1 Amount

  • ACHV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ACHIEVE LIFE SCIENCES INC

NASDAQ:ACHV (2/20/2026, 8:15:46 PM)

After market: 4.15 -0.12 (-2.81%)

4.27

-0.1 (-2.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)03-12
Inst Owners44.15%
Inst Owner Change34.95%
Ins Owners4.54%
Ins Owner Change19.89%
Market Cap227.29M
Revenue(TTM)N/A
Net Income(TTM)-52.35M
Analysts81.54
Price Target15.3 (258.31%)
Short Float %13.49%
Short Ratio10.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.21%
Min EPS beat(2)-6.75%
Max EPS beat(2)0.34%
EPS beat(4)2
Avg EPS beat(4)-4.14%
Min EPS beat(4)-10.29%
Max EPS beat(4)0.34%
EPS beat(8)3
Avg EPS beat(8)-5.36%
EPS beat(12)6
Avg EPS beat(12)-0.04%
EPS beat(16)7
Avg EPS beat(16)-3.08%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.44%
PT rev (3m)-2.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.74%
EPS NY rev (1m)0%
EPS NY rev (3m)-15.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.76
P/tB 7.15
EV/EBITDA N/A
EPS(TTM)-1.38
EYN/A
EPS(NY)-1.15
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS0
BVpS0.63
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -100.59%
ROE -155.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-132.77%
ROA(5y)-100.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.14
Quick Ratio 5.14
Altman-Z -1.42
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y-3.94%
EPS Next 2Y3.32%
EPS Next 3Y23.61%
EPS Next 5Y28.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-67.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-30.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.12%
OCF growth 3YN/A
OCF growth 5YN/A

ACHIEVE LIFE SCIENCES INC / ACHV FAQ

What is the fundamental rating for ACHV stock?

ChartMill assigns a fundamental rating of 1 / 10 to ACHV.


What is the valuation status of ACHIEVE LIFE SCIENCES INC (ACHV) stock?

ChartMill assigns a valuation rating of 1 / 10 to ACHIEVE LIFE SCIENCES INC (ACHV). This can be considered as Overvalued.


What is the profitability of ACHV stock?

ACHIEVE LIFE SCIENCES INC (ACHV) has a profitability rating of 0 / 10.